LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 139 filers reported holding LEGEND BIOTECH CORP in Q4 2021. The put-call ratio across all filers is 1.87 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $296,153 | -13.9% | 4,409 | -11.5% | 0.18% | -11.8% |
| Q2 2023 | $343,907 | +20.1% | 4,982 | -16.1% | 0.20% | +29.1% |
| Q1 2023 | $286,330 | -1.6% | 5,938 | +1.8% | 0.16% | +3.9% |
| Q4 2022 | $291,133 | +33.5% | 5,832 | +9.0% | 0.15% | +74.7% |
| Q3 2022 | $218,000 | -24.8% | 5,351 | +1.5% | 0.09% | -18.7% |
| Q2 2022 | $290,000 | +150.0% | 5,274 | +65.1% | 0.11% | +105.8% |
| Q1 2022 | $116,000 | -26.6% | 3,195 | -5.6% | 0.05% | -13.3% |
| Q4 2021 | $158,000 | -40.6% | 3,384 | -35.7% | 0.06% | -48.7% |
| Q3 2021 | $266,000 | +17.2% | 5,265 | -4.8% | 0.12% | +25.8% |
| Q2 2021 | $227,000 | -22.0% | 5,531 | -44.8% | 0.09% | -24.4% |
| Q1 2021 | $291,000 | +5.1% | 10,016 | +1.9% | 0.12% | +7.0% |
| Q4 2020 | $277,000 | – | 9,834 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |